Login / Signup

Circulating CD15+ LOX-1+ PMN-MDSCs are a potential biomarker for the early diagnosis of non-small-cell lung cancer.

Xinyu TianTing WangQisi ZhengYue TaoLei DaiHan Shen
Published in: International journal of clinical practice (2021)
Circulating CD15+ LOX-1+ PMN-MDSCs are a potential diagnostic marker for NSCLC, and are associated with NSCLC prognosis and recurrence after surgery.
Keyphrases
  • small cell lung cancer
  • advanced non small cell lung cancer
  • nk cells
  • brain metastases
  • risk assessment
  • human health
  • epidermal growth factor receptor
  • tyrosine kinase